← Back
Data updated: Jun 12, 2026
AUXILIUM PHARMS LLC
Biotech Pharmaceuticals
AUXILIUM PHARMS LLC is a biotechnology company with 2 FDA-approved products.
2003
Since
2
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Biologics
AUXILIUM PHARMS LLC's Key Drugs
AUXILIUM PHARMS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
AUXILIUM PHARMS LLC's Recent FDA Approvals
New NDA/BLA approvals for AUXILIUM PHARMS LLC over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
AUXILIUM PHARMS LLC's Therapeutic Areas
Disease areas where AUXILIUM PHARMS LLC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
AUXILIUM PHARMS LLC Pipeline Snapshot
Active clinical trials for AUXILIUM PHARMS LLC across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2003-06-19
- Latest
- 2024-10-11
- Applications
- 2
FDA Sponsor Names
AUXILIUM PHARMS LLCAUXILIUM PHARMS